Targeting Human MicroRNA Genes Using Engineered Tal-Effector Nucleases (TALENs)

MicroRNAs (miRNAs) have quickly emerged as important regulators of mammalian physiology owing to their precise control over the expression of critical protein coding genes. Despite significant progress in our understanding of how miRNAs function in mice, there remains a fundamental need to be able to target and edit miRNA genes in the human genome. Here, we report a novel approach to disrupting human miRNA genes ex vivo using engineered TAL-effector (TALE) proteins to function as nucleases (TALENs) that specifically target and disrupt human miRNA genes. We demonstrate that functional TALEN pairs can be designed to enable disruption of miRNA seed regions, or removal of entire hairpin sequences, and use this approach to successfully target several physiologically relevant human miRNAs including miR-155*, miR-155, miR-146a and miR-125b. This technology will allow for a substantially improved capacity to study the regulation and function of miRNAs in human cells, and could be developed into a strategic means by which miRNAs can be targeted therapeutically during human disease.

[1]  Ryan M. O’Connell,et al.  MicroRNA control in the development of systemic autoimmunity , 2013, Arthritis Research & Therapy.

[2]  T. Cathomen,et al.  Differential integrity of TALE nuclease genes following adenoviral and lentiviral vector gene transfer into human cells , 2012, Nucleic acids research.

[3]  Daniel F. Voytas,et al.  Simple Methods for Generating and Detecting Locus-Specific Mutations Induced with TALENs in the Zebrafish Genome , 2012, PLoS genetics.

[4]  G. Pedraza-Alva,et al.  Role of microRNAs in central nervous system development and pathology , 2012, Journal of neuroscience research.

[5]  A. Salviati,et al.  Genetic Association and Altered Gene Expression of Mir-155 in Multiple Sclerosis Patients , 2011, International journal of molecular sciences.

[6]  A. Bogdanove,et al.  TAL Effectors: Customizable Proteins for DNA Targeting , 2011, Science.

[7]  Koh Ono,et al.  MicroRNAs and cardiovascular diseases , 2011, The FEBS journal.

[8]  Erin L. Doyle,et al.  Efficient design and assembly of custom TALEN and other TAL effector-based constructs for DNA targeting , 2011, Nucleic acids research.

[9]  Elo Leung,et al.  A TALE nuclease architecture for efficient genome editing , 2011, Nature Biotechnology.

[10]  Angie Rizzino,et al.  Emerging roles of microRNAs in the control of embryonic stem cells and the generation of induced pluripotent stem cells. , 2010, Developmental biology.

[11]  Ryan M. O’Connell,et al.  Physiological and pathological roles for microRNAs in the immune system , 2010, Nature Reviews Immunology.

[12]  Barbara Jarzab,et al.  Common SNP in pre-miR-146a decreases mature miR expression and predisposes to papillary thyroid carcinoma , 2008, Proceedings of the National Academy of Sciences.

[13]  W. Filipowicz,et al.  Mechanisms of post-transcriptional regulation by microRNAs: are the answers in sight? , 2008, Nature Reviews Genetics.

[14]  Toni Cathomen,et al.  Structure-based redesign of the dimerization interface reduces the toxicity of zinc-finger nucleases , 2007, Nature Biotechnology.

[15]  Thuy D Vo,et al.  Enhancing zinc-finger-nuclease activity with improved obligate heterodimeric architectures , 2011, Nature Methods.

[16]  W. Filipowicz,et al.  The liver-specific microRNA miR-122: biology and therapeutic potential. , 2011, Progress in drug research. Fortschritte der Arzneimittelforschung. Progres des recherches pharmaceutiques.